25.04.2024 08:20:31 - dpa-AFX: *HIKMA PHARMA STILL EXPECTS FY REVENUE GROWTH TO BE 4% TO 6%

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
HIKMA PHARMACEUTIC.LS-,10 A0HG69 Frankfurt 21,800 04.07.24 21:49:53 +0,200 +0,93% 0,000 0,000 21,600 21,800

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH